Page last updated: 2024-09-05

roxifiban and Vascular Diseases

roxifiban has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, YC; Billheimer, JT; Cromley, DA; Daly, RN; Ebling, W; He, B; Hollis, GF; Hua, TA; Kieras, CJ; Pedicord, DL; Pieniaszek, HJ; Rossi, RJ; Seiffert, D; Sferruzza, A; Stein, RB; Stern, AM; Wynn, R	1
Mousa, SA	1

Trials

1 trial(s) available for roxifiban and Vascular Diseases

Article	Year
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia. Blood, 2003, Jan-01, Volume: 101, Issue:1 Topics: Amidines; Autoantibodies; Blood Platelets; Humans; Incidence; Isoxazoles; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombocytopenia; Time Factors; Vascular Diseases	2003

Article

Year

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia.

Blood, 2003, Jan-01, Volume: 101, Issue:1

Topics: Amidines; Autoantibodies; Blood Platelets; Humans; Incidence; Isoxazoles; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombocytopenia; Time Factors; Vascular Diseases

2003

Other Studies

1 other study(ies) available for roxifiban and Vascular Diseases

Article	Year
Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disorders. Seminars in thrombosis and hemostasis, 2000, Volume: 26 Suppl 1 Topics: Amidines; Antifibrinolytic Agents; Blood Coagulation; Clot Retraction; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Isoxazoles; Kinetics; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombelastography; Tinzaparin; Vascular Diseases	2000

Article

Year

Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disorders.

Seminars in thrombosis and hemostasis, 2000, Volume: 26 Suppl 1

Topics: Amidines; Antifibrinolytic Agents; Blood Coagulation; Clot Retraction; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Isoxazoles; Kinetics; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombelastography; Tinzaparin; Vascular Diseases

2000